ArticleCureus2026
Clinical Characteristics, Surgical Risks, and Long-Term Prognosis of Good's Syndrome.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective Good's syndrome (GS), a rare condition characterized by thymoma with hypogammaglobulinemia, is associated with recurrent infections and poorer prognosis. Advances in minimally invasive procedures, such as video-assisted thoracoscopic surgery (VATS) and robotic-assisted thoracoscopic surgery (RATS), may help reduce perioperative complications in thymoma surgery. Given these considerations, we aimed to evaluate the surgical outcomes and long‑term prognosis of patients with GS undergoing thymectomy, with particular attention to minimally invasive approaches, such as VATS and RATS. Methods We retrospectively reviewed thymectomy cases at Hokkaido University Hospital (2007-2024). Clinical background, surgical procedures, and outcomes were compared between GS and non-GS patients. Survival was analyzed using Kaplan-Meier curves and log-rank tests. We also conducted a detailed evaluation of perioperative management and long-term outcomes in the seven patients with GS. Results Among 104 thymectomy cases, seven had GS. All GS patients had type AB thymoma, significantly more frequent than in non-GS cases. Surgical approaches included median sternotomy (n=2), VATS (n=2), and RATS (n=3). Perioperative outcomes were comparable to those of non-GS patients. However, immunodeficiency persisted, and five GS patients developed severe late postoperative infections, leading to two deaths. Additional late complications included extrathymic malignancies (n=2) and pure red cell aplasia (n=3). Despite the limited sample size, overall survival was significantly worse in GS patients (p=0.002). Conclusions Thymectomy for GS can be performed safely, including VATS and RATS. Nevertheless, long-term prognosis remains poor because of persistent immunodeficiency, leading to severe infections and secondary malignancies, highlighting the need for vigilant postoperative management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.